Skip to main content

Table 4 The extrapolated health care costs (in Swiss Francs) in IBD versus non-IBD patients between 2010 and 2014

From: Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014

Mean (CI, median)

IBD

non-IBD

p a

2010

Total

9590 (9210-9970, 5390)

3160 (3140-3170, 750)

<0.001

 Inpatient

2040 (1830-2240, 0)

890 (880-890, 0)

<0.001

 Outpatient

3920 (3790-4040, 2810)

1510 (1500-1510, 490)

<0.001

 Medication

3630 (3430-3840, 1700)

760 (760-770, 100)

<0.001

2012

Total

11,680 (11,230-12,140, 6090)

3380 (3360-3390, 780)

<0.001

 Inpatient

2080 (1860-2300, 0)

950 (940-960, 0)

<0.001

 Outpatient

4470 (4300-4640, 3110)

1630 (1630-1640, 520)

<0.001

 Medication

5130 (4840-5430, 1900)

790 (790-800, 110)

<0.001

2014

Total

12,790 (12,270-13,300, 6810)

3540 (3520-3560, 870)

<0.001

 Inpatient

2150 (1870-2430, 0)

910 (900-920, 0)

<0.001

 Outpatient

5280 (5070-5490, 3510)

1830 (1830-1840, 610)

<0.001

 Medication

5360 (5100-5620, 1900)

800 (790-800, 110)

<0.001

  1. a p-values were calculated using multivariate linear regression (adjusted for age group, sex, and canton of residence)